A Research Study to Assess the Mechanism By Which Glucovance, Metformin, and Glyburide Work To Control Glucose Levels In Patients With Type 2 Diabetes
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00035568 |
Recruitment Status :
Completed
First Posted : May 6, 2002
Last Update Posted : April 15, 2011
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Diabetes Mellitus, Non-Insulin-Dependent | Drug: Glucovance (metformin HCl/glyburide) Drug: or Metformin HCl alone Drug: or Glyburide alone. | Phase 4 |
Study Type : | Interventional (Clinical Trial) |
Primary Purpose: | Treatment |
Study Start Date : | February 2002 |
Actual Primary Completion Date : | June 2003 |
Actual Study Completion Date : | June 2003 |


Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 20 Years to 75 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00035568
United States, Arkansas | |
Local Institution | |
Little Rock, Arkansas, United States | |
United States, California | |
Local Institution | |
Los Angeles, California, United States | |
United States, Illinois | |
Local Institution | |
Chicago, Illinois, United States | |
United States, Indiana | |
Local Institution | |
Indianapolis, Indiana, United States | |
United States, New York | |
Local Institution | |
Brooklyn, New York, United States | |
Local Institution | |
Rochester, New York, United States | |
United States, Pennsylvania | |
Local Institution | |
Pittsburgh, Pennsylvania, United States | |
United States, Texas | |
Local Institution | |
Dallas, Texas, United States | |
Local Institution | |
San Antonio, Texas, United States |
ClinicalTrials.gov Identifier: | NCT00035568 |
Other Study ID Numbers: |
CV138-062 |
First Posted: | May 6, 2002 Key Record Dates |
Last Update Posted: | April 15, 2011 |
Last Verified: | April 2011 |
Type 2 Diabetes Mellitus |
Diabetes Mellitus Diabetes Mellitus, Type 2 Glucose Metabolism Disorders Metabolic Diseases Endocrine System Diseases |
Metformin Glyburide Hypoglycemic Agents Physiological Effects of Drugs |